Your Body Starts
Closing the Window
Your body starts closing the window on children years before you're ready to open it. A deep investigation into the biology of ovarian reserve depletion, the hidden collapse of male fertility, and the compounding mathematics of what happens when both sides decline simultaneously.
Google will tell you fertility declines with age. Wikipedia will give you the textbook statistics. What neither will show you is the mechanism: why the decline happens when it does, why male fertility is collapsing independently of female fertility, and what the compounding effect looks like when both sides of the equation degrade simultaneously.
The Average Age of First Birth Has Risen Seven Years in Half a Century
The average age at which a woman in England and Wales has her first child has risen by more than seven years in half a century. In the early 1970s, the standardised mean age of a first-time mother sat at approximately 23.5 years. By 2020, that figure had reached a record high of 30.7 years, where it has since remained.
This is not a uniquely British phenomenon. Across the OECD, the mean age at first birth has increased by between two and five years since 1970, with the largest increases concentrated in Southern and Western Europe. In Italy and Spain, the average first-time mother is now over 31. In the United States, the median age at first birth rose from 22.6 years in 1980 to 27.9 years in 2023.
The pattern is consistent: as societies become more educated, more economically complex, and more reliant on dual incomes, the decision to have children gets pushed further into the third decade of life.
The most common age at childbirth for women born in 1975 was 31 years — compared with 22 years for their mothers' generation born in 1949.
— Office for National Statistics, 2022
The problem is not the delay itself. The problem is the gap between when couples feel ready and when their reproductive biology is optimally positioned to cooperate. That gap is now, on average, a decade wide — and it is getting wider.
The Biological Reality Is a Continuous, Accelerating Depletion
The popular shorthand for female fertility decline — "it drops after 35" — is not wrong, but it is profoundly incomplete. It creates a mental model in which a woman has roughly stable fertility through her twenties and early thirties, then experiences a moderate decline. The biological reality is a continuous, accelerating depletion that begins before birth and ends at menopause. The cliff is not at 35. It is at 37.
Lifetime Oocyte Count
at 20 weeks gestation
puberty
age 37
ovulated in lifetime
A female foetus reaches peak egg count at approximately 20 weeks of gestation, when the ovaries contain an estimated 6 to 7 million oocytes. By birth, this number has already fallen to between 1 and 2 million — a loss of over 80% before the child has drawn a breath. The process responsible is atresia: the programmed, continuous death of follicles that occurs regardless of hormonal stimulation, pregnancy, or contraceptive use. By puberty, the reserve has declined to approximately 300,000 to 500,000 eggs, of which only around 400 will ever be ovulated.
The Real Cliff: Age 37, Not 35
The age-35 threshold entered clinical consciousness because it was the point at which obstetric risk — particularly chromosomal abnormalities — became statistically significant enough to warrant additional screening. The actual biology is more specific.
Research by Wallace and Kelsey identified a critical inflection point at approximately age 37–38, at which the rate of follicle loss doubles. Before this point, a woman loses roughly 1,000 follicles per month. After it, the rate accelerates sharply, and the remaining reserve — already down to approximately 25,000 — depletes rapidly toward the menopausal threshold of around 1,000 follicles.
| Age | Est. Ovarian Reserve | Monthly Conception Probability | Aneuploidy Rate (approx.) | 12-Month Conception Rate |
|---|---|---|---|---|
| 25 | ~150,000 | 25–28% | ~20% | ~97% |
| 30 | ~72,000 | 22–25% | ~25% | ~93% |
| 35 | ~35,000 | 15–18% | ~40% | ~78% |
| 37 | ~25,000 | 12–15% ⚡ | ~50% | ~68% |
| 40 | ~10,000 | 5–8% | ~60–70% | ~36% |
| 43 | ~3,000 | 2–4% | ~80–90% | ~18% |
⚡ Age 37 marks the inflection point at which the rate of follicle loss doubles. Sources: Wallace & Kelsey (2010); Dunson et al. (2002); Owen et al. (2024).
The Perception Gap
Perhaps the most consequential finding in the fertility literature is not biological but psychological: women consistently and substantially overestimate how long they have.
A large-scale survey of over 97,000 women trying to conceive found that 41% could not accurately identify their fertile window within the menstrual cycle. More strikingly, a 2022 study found that the average IVF patient expected a 59% success rate from treatment — more than double the actual rate for most age groups.
A prospective study presented at the European Society of Human Reproduction and Embryology found that 85% of female IVF patients overestimated their chances of a live birth by an average of 34 percentage points.
This perception gap is not a failure of intelligence. It is a failure of education. The cultural messaging around fertility — from media representations of late-life pregnancies to the prominence of IVF success stories — has systematically distorted the public's understanding of the biological timeline.
Male Reproductive Health Is In Freefall
The conversation about fertility has, for decades, been almost exclusively about women. Male fertility is culturally invisible — rarely discussed, rarely tested, and rarely considered in the context of delayed family planning. This invisibility is becoming a serious problem, because male reproductive health is in freefall.
The Sperm Count Crisis
In 2017, Dr. Hagai Levine of the Hebrew University of Jerusalem and colleagues published a meta-analysis in Human Reproduction Update that sent shockwaves through the reproductive science community. Analysing data from 185 studies covering 42,935 men across 50 countries, they found that sperm concentration among men in Western countries had declined by 52.4% between 1973 and 2011 — a decline of 1.4% per year.
In 2022, Levine and his team published an updated analysis incorporating data from 53 countries and extending the observation period to 2018. Global sperm concentration had fallen by 51.6%, from 101 million per milliliter in 1973 to just 49 million per milliliter in 2018. Total sperm count — which accounts for both concentration and volume — had dropped by 62.3%. Critically, the rate of decline appears to be accelerating: from 1.16% per year in the period before 2000 to 2.64% per year thereafter.
To contextualise these numbers: the World Health Organisation defines a sperm concentration below 16 million per milliliter as below the reference range for fertile men. At the current trajectory, the global average will approach this threshold within decades.
If current trends continue, the median sperm count will reach zero by 2045 — a projection that illustrates the severity of the trend.
The Testosterone Decline
Parallel to the collapse in sperm counts is a population-wide decline in testosterone levels that is independent of individual aging. A landmark study by Travison and colleagues, published in the Journal of Clinical Endocrinology and Metabolism in 2007, analysed testosterone levels in three successive cohorts of men measured in 1987–1989, 1995–1997, and 2002–2004.
The finding was striking: each successive cohort had significantly lower testosterone than the previous cohort at the same age. A 60-year-old man measured in 2004 had testosterone levels approximately 17% lower than a 60-year-old man measured in 1987 — even after controlling for age, obesity, smoking, and alcohol use.
This is not aging. This is a secular trend — a change in the population baseline that is occurring independently of how old any individual man is. A man born in 1990 will, on average, have lower testosterone at age 35 than his father did at the same age, and lower still than his grandfather. The cumulative effect across generations is substantial.
What Is Causing It? Competing Hypotheses
Endocrine-Disrupting Chemicals (EDCs)
Phthalates (found in plastics, cosmetics, food packaging) and bisphenol A (BPA) mimic oestrogen and block androgen receptors, directly interfering with testosterone synthesis and spermatogenesis. Cross-sectional studies in humans show BPA exposure correlates with a 10–15% reduction in blood testosterone. Animal studies confirm causal mechanisms.
These chemicals are ubiquitous: found in food packaging, personal care products, receipts, and the lining of tin cans. Prenatal exposure appears to have the most severe effects.
Obesity and Metabolic Dysfunction
Adipose tissue converts testosterone to oestrogen via aromatase. Obese men have significantly lower testosterone and sperm quality than lean men, independent of age. Given that global obesity rates have tripled since 1975, this is a plausible contributor to population-level trends. The relationship is dose-dependent and partially reversible with weight loss.
Microplastics in Testicular Tissue
A 2024 study published in Toxicological Sciences found microplastics in 100% of human testicular tissue samples tested, at concentrations three times higher than in animal testes. Higher concentrations of specific microplastics correlated with reduced sperm counts and testis weight. The causal pathway — disruption of the blood-testis barrier and oxidative stress — has been demonstrated in animal models.
Sedentary Lifestyle and Heat Exposure
Spermatogenesis requires a scrotal temperature approximately 2–4°C below core body temperature. Prolonged sitting, tight clothing, and laptop use on the lap all elevate scrotal temperature. Studies show sustained scrotal hyperthermia reduces sperm production by 40% or more. The modern sedentary work environment is a plausible, if underquantified, contributor.
The hypothalamic-pituitary-gonadal (HPG) axis is the hormonal cascade that regulates testosterone production and spermatogenesis. EDCs like phthalates inhibit the Leydig cells in the testes that produce testosterone. BPA binds to oestrogen receptors and competes with androgens for androgen receptors, reducing their effectiveness. The underreporting of male fertility decline is itself a cultural phenomenon — male infertility carries significant social stigma.
When Both Partners Delay, The Numbers Get Worse Fast
The two trends described above — female ovarian reserve depletion and the population-wide collapse of male fertility — are typically discussed in isolation. The more important question is what happens when they interact. When both partners delay, and when the male partner's fertility has been degraded by environmental factors independent of his age, the combined probability of conception drops faster than either factor alone would suggest.
Monthly Fecundability by Female Age
(With fertile male partner)
| Female Age | Monthly Probability | 12-Month Cumulative | Time to 50% Chance |
|---|---|---|---|
| 20–24 | ~25–28% | ~97% | ~2 months |
| 25–29 | ~22–25% | ~93% | ~3 months |
| 30–34 | ~18–22% | ~86% | ~3–4 months |
| 35–37 | ~12–15% | ~68–78% | ~4–5 months |
| 38–39 | ~8–12% | ~55–65% | ~6 months |
| 40–42 | ~5–8% | ~36–48% | ~9–12 months |
| 43–44 | ~2–4% | ~18–28% | >18 months |
Sources: Dunson et al. (2002) Human Reproduction; ASRM Committee Opinion (2022); Steiner & Jukic (2016).
The Compounding Effect With Population-Level Male Decline
The figures above assume an optimally fertile male partner. They do not account for the population-level decline in sperm counts documented by Levine et al. When we introduce a male fertility modifier — reflecting both age-related decline and the population-wide environmental degradation of sperm quality — the combined probabilities shift dramatically.
Over a 12-month period, the optimal couple has a 97% cumulative chance of conceiving; the delayed couple with population-level male fertility decline has a 67% chance. That is a 64% reduction in monthly probability. These are not edge cases. They represent the realistic position of a significant proportion of couples in the UK who are delaying family formation in line with the national average.
The Safety Net That Isn't
The most dangerous assumption in modern fertility planning is that IVF provides a reliable backstop for delayed parenthood. It does not — and the gap between what people believe IVF can do and what it actually delivers is one of the most consequential misunderstandings in reproductive health.
| Age Group | Actual Birth Rate (2023) | Actual Birth Rate (2013) | What Patients Expect | Overestimation |
|---|---|---|---|---|
| 18–34 | 35% | 24% | ~59% | +24 pp |
| 35–37 | 25% | 17% | ~55% | +30 pp |
| 38–39 | 17% | 11% | ~48% | +31 pp |
| 40–42 | 9% | 6% | ~40% | +31 pp |
| 43–44 | 5% | 3% | ~30% | +25 pp |
pp = percentage points. Birth rates per fresh embryo transfer using own eggs. HFEA 2023 data.
According to the HFEA's 2023 data, the birth rate per fresh embryo transfer for patients using their own eggs was 35% for those aged 18–34, falling to 25% at ages 35–37, 17% at 38–39, 9% at 40–42, and just 5% for patients aged 43–44.
A single IVF cycle — which costs between £5,000 and £10,000 privately in the UK — has a one-in-twenty chance of producing a live birth for a 43-year-old woman using her own eggs.
Against these figures, the average IVF patient expects a success rate of approximately 59%. A prospective study of couples entering IVF found that 85% of female patients overestimated their chances of a live birth by an average of 34 percentage points. Almost half expected their birth rate to exceed 50%. This is not optimism. It is a systematic failure of informed consent.
Why This Matters Right Now
The three trends described in this document are not independent. They are converging, and the convergence is happening at precisely the moment when the average couple in the UK is making their fertility decisions.
The average age of first birth has risen to 30.7 years. The female fertility cliff begins at 37 — just 6.3 years away from the average starting point. Male fertility has been declining at the population level for fifty years, and the rate of decline is accelerating. IVF, the technology that couples assume will bridge the gap, has success rates that are a fraction of what people believe them to be.
The result is a compounding of biological and informational failures. Couples delay because they believe they have more time than they do. They underestimate the male fertility component because it is culturally invisible. They overestimate IVF because it is culturally over-represented. And by the time they seek help, they are often operating in a window where the probability of success — natural or assisted — has already declined substantially.
This is not an argument against delay. The social and economic forces driving later family formation are real, and the decision of when to have children is deeply personal. It is an argument for accurate information — for understanding the actual biological timeline, the actual male fertility data, and the actual IVF success rates, so that decisions can be made with clear eyes rather than optimistic assumptions.
By the time the average couple in the UK decides they're ready for children, their combined probability of conceiving in any given month has already halved. Male fertility is declining at 1% every year at the population level, and almost nobody is talking about it. The average IVF patient expects a 59% success rate. For a 43-year-old using her own eggs, the actual figure is 5%.
"Your body starts closing the window on children years before you're ready to open it. For women, the real cliff is at 37, not 35. Male fertility has been collapsing for fifty years. And by the time you decide you're ready, you're probably operating in a window where the probability of success has already dropped by half. That's not a personal failure — it's biology running into a timeline collapse."
You’ve looked beneath the surface.
Now follow the connection.
Explore this article’s connections ↗Population Collapse →
The five-part investigation into falling birth rates.